messaggio

clik on the image and visit the new site

New site clik on the image

"In silico"


From Wikipedia
If the target host* of a phage therapy treatment is not an animal the term "biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".

In silico
From:"Genomics,Proteomics and Clinical Bacteriology",N.Woodford and Alan P.Johnson

Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.


Phage Therapy is influenced by:

Phage therapy is influenced by:

Country : the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Temporariness
Mutation rate
Phenotypical delay
Phage cocktail

My point of view

Tuesday 10 March 2009

Second Quadrilateral Apex: Bacteriophages

From:
BACTERIOPHAGES
Biology and Applications


EDITED BY
Elizabeth Kutter
Alexander Sulakvelidze

Written by
Karin Carlson
Department of Cell and Molecular Biology,
University of Uppsala, Uppsala, Sweden


Phage Stocks




General Considerations


Phages are fairly fragile and should be handled gently and not to expose them to osmotic shock, or to strong daylight or fluorescent light.

Vigorous mixing of phage solutions with a pipette and aggressive vortexing should also be avoided.

The time during which phages maintain full viability varies considerably.

The titers of
phage stocks should be determined at the time they are prepared, and also shortly before their use.

A phage stock that has been stored cold for some time can be warmed to 37° for 5–10 min and gently mixed in order to disaggregate phage clumps.

Phage stocks (like stocks of microorganisms) should not be routinely propagated by serial passage, because variants that grow faster than the original strain will increase in frequency with every round of growth.

An archival or “master stock” of each phage strain should be maintained, preferably in aliquots kept in different places as a precaution against laboratory accidents.

New working stocks should be grown from this stock as required.

Phage stocks can be prepared in any medium that permits growth of the bacterial host strain.

During propagation, mutations will arise.

It is prudent to start new phage stocks from single plaques but there is a risk that the selected plaque was formed by a nondesired variant phage. An appropriate balance must be determined on a case-by-case basis between using single plaques to start cultures and picking 2–3 plaques to avoid the risk of accidentally selecting a variant.

It is advisable that the properties of new phage stocks be compared with the original stock’s known properties.

Lytic phage progeny are harvested after they are released from their host bacteria by cell lysis.

If the phages do not contain lipids, chloroform can be added to the infected cells to release the progeny phages and reduce their adsorption to bacteria and bacterial debris.

A lysed culture is commonly centrifuged or filtered to remove bacterial debris, and the resulting suspension is commonly referred to as a “cleared lysate.”